v3.26.1
SHARE-BASED COMPENSATION (Tables)
9 Months Ended
Aug. 02, 2026
SHARE-BASED COMPENSATION [Abstract]  
Share-based Compensation Expenses The table below presents information on the Company’s share-based compensation expenses.
                     
 
Three Months Ended  
Nine Months Ended  
    August 2,
2026
    August 3,
2025
    August 2,
2026
    August 3,
2025
 
 
Expense reported in:
                   
Cost of goods sold
 $977   $816   $2,801   $2,378 
Selling, general, and administrative
  2,729    2,174    7,869    6,729 
Research and development
  155    304    (233   896 
Total expense incurred
 $3,861   $3,294   $10,437   $10,003 
                     
Expense by award type:
                   
Restricted stock awards
 $2,275   $2,943   $6,516   $9,029 
Restricted stock units
  1,547    294    3,806    803 
Employee stock purchase plan
  39    57    115    171 
Total expense incurred
 $3,861   $3,294   $10,437   $10,003 
                     
Income tax benefits on share-based compensation
 $787   $461   $2,149   $1,313 
Restricted Stock Awards Activity The table below presents information on the Company’s restricted stock awards.
                 
 

Three Months Ended  

Nine Months Ended  
   
August 2,
2026
   
August 3,
2025
   
August 2,
2026
   
August 3,
2025
 
Number of shares granted in period
   -      -      -     583,238 
Weighted-average grant-date fair value of awards (in dollars per share)
 $ -    $ -    $ -    $23.42 
Compensation cost not yet recognized
 $13,256   $24,414   $13,256   $24,414 
Weighted-average amortization period for cost not yet recognized (in years)
  2.0    2.8    2.0    2.8 
Restricted shares outstanding at balance sheet date
  800,761    1,421,897    800,761    1,421,897 
Restricted Stock Units Activity The table below presents information on the Company’s restricted stock unit awards.
                 
 

Three Months Ended  

Nine Months Ended  
    
August 2,
2026
    
August 3,
2025
    
August 2,
2026
    
August 3,
2025
 
Number of units granted in period
  10,021    109,830    599,622    162,666 
Weighted-average grant-date fair value of awards (in dollars per share)
 $28.94   $18.21   $33.91   $19.61 
Compensation cost not yet recognized
 $15,940   $2,387   $15,940   $2,387 
Weighted-average amortization period for cost not yet recognized (in years)
  3.3    3.3    3.3    3.3 
Restricted stock units outstanding at balance sheet date
  650,171    132,474    650,171    132,474 
Stock Options Activity The table below presents information on the Company’s stock options.
 

Three Months Ended  

Nine Months Ended  
   
August 2,
2026
   
August 3,
2025
   
August 2,
2026
   
August 3,
2025
 
Number of options granted in period
   -      -      -      -  
Cash received from options exercised
 $9   $400   $1,001   $1,698 
Compensation cost not yet recognized
 $ -    $ -    $ -    $ -  
Weighted-average amortization period for cost not yet recognized (in years)
   -      -      -      -  
Outstanding and Exercisable Option
Information regarding outstanding and exercisable option awards as of August 2, 2026, is presented below.
 
 
 
 
 
Options
  
 
 
Shares
    
 
Weighted
Average
Exercise
Price
    
Weighted
Average
Remaining
Contractual
Life (in years)
    
Aggregate
Intrinsic
Value
 
Outstanding and exercisable at August 2, 2026
  18,250   $9.56    1.55   $378